Cite
MLA Citation
T.E. Cummin et al.. “ACCEPT: A PHASE IB/II COMBINATION OF ACALABRUTINIB WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (R‐CHOP) FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL).” Hematological oncology, vol. 37, n.d., pp. 71–72. http://access.bl.uk/ark:/81055/vdc_100086208697.0x00003b